Esomeprazole
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Esomeprazole and local guidelines before prescribing.
Mechanism
Proton pump inhibitor irreversibly inhibiting H+/K+ ATPase.
Uses
GORD, peptic ulcer and prevention with NSAIDs, H. pylori regimens, Zollinger-Ellison.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Headache, diarrhoea; hypomagnesaemia, B12 deficiency, fracture risk, C. difficile, microscopic colitis with long-term use.
Interactions
Clopidogrel activation reduced; levothyroxine and iron absorption reduced; methotrexate levels rise.
Contraindications and cautions
Co-prescription with nelfinavir
Monitoring
Magnesium, B12 long term
Pregnancy and breastfeeding
Considered acceptable
Renal and hepatic impairment
Reduce dose in severe liver impairment
Overdose and reversal
Supportive
Special advice
Review long-term need; use lowest effective dose.
More from the textbook: uses, cautions and other points
- Omeprazole and esomeprazole inhibit CYP2C19 → less activation of clopidogrel (avoid the combination - use lansoprazole or pantoprazole).
Gastroenterology: Anatomy Physiology Pharmacology - Clopidogrel: Omeprazole and esomeprazole reduce its activation - use lansoprazole or pantoprazole instead.
Gastroenterology: Oesophagus and Stomach - Clopidogrel - a prodrug activated by CYP2C19 (poor metabolisers and omeprazole or esomeprazole reduce its effect - use lansoprazole or pantoprazole); used after stroke, in peripheral arterial disease and with aspirin after ACS or stents.
Haematology: Anatomy Physiology and Pharmacology
Where it is discussed in the book
- Gastroenterology: Anatomy Physiology Pharmacology (1 mention)
- Gastroenterology: Oesophagus and Stomach (1 mention)
- Haematology: Anatomy Physiology and Pharmacology (1 mention)